DTC Healthcare with 23andMe CEO Anne Wojcicki
Motley Fool Money
Analyzing the Future of 23andMe: Innovation and Data Assets
This chapter examines the health and prospects of 23andMe, highlighting the company's dual focus on consumer and therapeutic services. It underscores the significance of its data assets and the imperative for ongoing innovation and financial stability in the evolving landscape of genetic health care.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
